Influenza A and influenza B are the two types of flu virus responsible for the seasonal outbreaks that hit most winters. Both cause the same familiar symptoms, both can land you in the hospital, and both are covered by the annual flu vaccine. The differences between them come down to how they’re classified, how they evolve, and which populations they tend to hit hardest.
How Flu A and Flu B Are Classified
Influenza A viruses are sorted into subtypes based on two proteins on their surface: hemagglutinin (H) and neuraminidase (N). There are 18 H subtypes and 11 N subtypes, creating a huge number of possible combinations. That’s where names like H1N1 and H3N2 come from. More than 130 subtype combinations have been found in nature, mostly in wild birds, though only a handful regularly infect people.
Influenza B doesn’t have subtypes at all. Instead, it’s split into two lineages: B/Victoria and B/Yamagata. These lineages behave more like two branches of the same family tree, mutating more slowly and circulating almost exclusively in humans rather than jumping between species.
Why Only Flu A Causes Pandemics
Flu viruses change in two ways. The first, called antigenic drift, involves small, gradual mutations that happen in both A and B. Drift is the reason you need a new flu shot every year: the virus surface changes just enough that your immune system doesn’t fully recognize it.
The second, called antigenic shift, is exclusive to influenza A. Shift is a sudden, major reshuffling of the virus’s surface proteins. It can happen when a flu virus from birds or pigs gains the ability to infect humans, producing a version so different that most people have zero immunity to it. That’s the recipe for a pandemic. Because influenza B circulates only in humans, it doesn’t have access to the animal reservoir that makes this kind of dramatic reinvention possible.
Severity: Closer Than You’d Think
Influenza A is often assumed to be the more dangerous of the two, partly because it causes more total infections each season and is the only type behind pandemics. But when researchers compared outcomes in hospitalized adults over eight flu seasons (2005 through 2013), they found no significant difference. Length of hospital stay, the proportion of patients admitted to an ICU, and the proportion of deaths were comparable between flu A and flu B.
The pattern holds in children, too. A study of hospitalized kids found the average stay was 2.3 days for flu A and 2.7 days for flu B, a gap that wasn’t statistically meaningful. About 13% of children hospitalized with flu A and 15% of those with flu B needed intensive care. Roughly 3% of the flu A group and 5% of the flu B group required mechanical ventilation. None of these differences reached statistical significance. In short, once either virus makes you sick enough to be hospitalized, both are equally capable of causing serious complications.
How Each Type Is Detected
Rapid influenza diagnostic tests, the kind you might get at an urgent care visit, can distinguish between flu A and flu B in about 15 minutes. These tests are required to catch at least 80% of true flu A and flu B infections when compared against the gold-standard lab method (RT-PCR), with a specificity of at least 95% for both types. That means a positive result is highly reliable, but a negative doesn’t completely rule out the flu, especially for type B, where rapid tests have historically been slightly less sensitive.
If your doctor suspects the flu despite a negative rapid test, a more precise molecular test can confirm or rule it out.
Treatment Differences
The standard antiviral medications work against both flu A and flu B, but not equally well for both. The most commonly prescribed option, oseltamivir (Tamiflu), is effective against both types, though clinical data is stronger for flu A simply because flu A infections are more common in studies.
A newer antiviral, baloxavir (Xofluza), appears to have an edge specifically for flu B. In a randomized trial, patients with influenza B who took baloxavir improved more than 24 hours faster than those who took oseltamivir. If you test positive for flu B, this is worth knowing about, as your provider may factor the virus type into which medication to prescribe.
What’s in the Flu Vaccine
For the 2024-2025 season, U.S. flu vaccines are trivalent, meaning they protect against three virus strains: two influenza A strains (an H1N1 and an H3N2) and one influenza B strain from the Victoria lineage. In previous years, vaccines were quadrivalent and included a second B strain from the Yamagata lineage, but that lineage has not been detected in global circulation recently, so it was dropped.
Getting vaccinated covers you against both flu A and flu B in a single shot. The specific strains are updated each year based on global surveillance of which viruses are circulating and how much they’ve drifted since the prior season.
Which Type Circulates When
Flu A typically dominates the early part of flu season, peaking in the winter months. Flu B often surges later, sometimes producing a second wave in late winter or early spring. In some years, flu B accounts for a significant share of total infections, particularly among school-age children. The timing and ratio shift from season to season, which is part of why tracking both types matters for public health planning and vaccine design.
Both types spread the same way: through respiratory droplets when an infected person coughs, sneezes, or talks, and through contact with contaminated surfaces. The incubation period, contagious window, and core symptoms (fever, body aches, cough, fatigue) are virtually identical for both. The virus type on your test result matters more for treatment decisions and epidemiological tracking than for anything you’d notice in how the illness feels.